XML 53 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
Debt (Tables)
9 Months Ended
Sep. 30, 2012
Debt [Abstract]  
Summary of financing
The following disclosures reflect a summary of our outstanding convertible securities, as well as activity related to financing transactions.  The table below summarizes the Company's financing, and further details regarding each transaction are provided following the table:
   
Convertible Line of Credit with Related Party
 
Convertible Senior Secured Promissory Note
     
       
Total
Face Value of Note
 
$
      1,300,000
 
$
      5,000,000
 
$
      6,300,000
Due date
 
(a)
12/31/2012
 
(b)
12/31/2013
     
Annual Interest rate
   
5%
   
5%
     
                   
Contingent warrants issued at inception (c):
                 
First Contingent Warrants
 
(d)
          325,000
 
(e)
      1,250,000
   
      1,575,000
Second Contingent Warrants
 
(f)
          325,000
 
(f)
      1,250,000
   
      1,575,000
Total Contingent Warrants
   
          650,000
   
      2,500,000
   
      3,150,000
                   
Warrants as of September 30, 2012:
                 
First Contingent Warrants - Vested
 
(d)
        (325,000)
 
(e)
    (1,250,000)
   
    (1,575,000)
Second Contingent Warrants - Voided
 
(f)
        (325,000)
 
(f)
    (1,250,000)
   
    (1,575,000)
                   
Contingent Warrants Outstanding as of September 30, 2012
                 
First Contingent Warrants
   
—  
   
—  
   
—  
Second Contingent Warrants
   
—  
   
—  
   
—  
Total Contingent Warrants Outstanding as of September 30, 2012
 
$
—  
 
$
—  
 
$
—  
Weighted average exercise price of warrants
 
 $
                   0.01
 
 $
                   0.01
     
 
 
(a) The initial termination date of the Credit Agreement is December 31, 2012 and the Company may elect to extend the termination date until December 31, 2013 upon payment of an extension fee of 5% of the outstanding principle balance or $65,000.

(b) Unless the Company has repaid the applicable lender's Notes in full prior to December 31, 2012, the Company must pay to each lender an additional interest payment in the amount of five percent (5%) of the aggregate outstanding principal amount of such lender's Notes as of December 31, 2012.

(c) The Contingent Warrants have a term of five years from the date of issuance; however each is subject to automatic terminations as defined in the First Contingent Warrant and Second Contingent Warrant terms. The shares of Common Stock issuable upon exercise of the Contingent Warrants do not carry registration rights and may be exercised on a "cashless" basis. In the event of a change in control transaction on or prior to the First Measurement Date, then the Contingent Warrants shall be exercisable immediately prior to the closing of such change in control transaction. In the event (i) of a change in control transaction after the First Measurement Date and on or prior to the Second Measurement Date and (ii) the per share value of the consideration received by the holders of Common Stock in such change in control transaction is at least $1.75, the Second Contingent Warrant shall be null and void. If the value of the per share consideration received by the holders of Common Stock in such transaction is less than $1.75, the Second Contingent Warrant shall be exercisable immediately prior to the closing of such change in control transaction.

(d) The First Contingent Warrant, (the "First Contingent Warrant") is issued to each investor to purchase 25% of the number of shares of Stock purchased, at an exercise price of $0.01 per share, provided that the First Contingent Warrant shall only be exercisable if the Company's Gross Revenue as reported in the Company's Audited Financial Statements for the year ended December 31, 2011, do not equal or exceed $11,500,000 and further provided that such Warrant shall be null and void in the event that prior to issuance of such Audited Financial Statements (the "First Measurement Date") the closing trading price of the Stock is at least $1.50 per share for ten or more consecutive trading days.  As of March 31, 2012, the First Contingent Warrants vested due to the Company's Gross Revenue not exceeding $11,500,000 for the year ended December 31, 2011, and due to the closing trading price of the stock not equaling or exceeding $1.50 per share for ten or more consecutive trading days.

(e) The First Contingent Warrant, (the "First Contingent Warrant") is issued to each investor to purchase 25% of the number of shares of Stock purchased, at an exercise price of $0.01 per share, provided that the First Contingent Warrant shall only be exercisable if the Company's Gross Revenue as reported in the Company's Audited Financial Statements for the year ended December 31, 2011, do not equal or exceed $11,500,000.  As of December 31, 2011, the First Contingent warrants vested due to the Company's Gross Revenue not exceeding $11,500,000 for the year ended December 31, 2011.

(f) The Second Contingent Warrant, (the "Second Contingent Warrant") is issued to each investor to purchase 25% of the number of shares of Stock purchased, at an exercise price of $0.01 per share, provided that the Second Contingent Warrant shall only be exercisable if the Company's Gross Revenue as reported in the Company's Audited Financial Statements for the year ended December 31, 2012, do not equal or exceed $31,150,000 and further provided that such Warrant shall be null and void in the event that prior to issuance of such Audited Financial Statements (the "Second Measurement Date") the closing trading price of the Stock is at least $1.75 per share for ten or more consecutive trading days. The second contingent warrants were voided on July 3, 2012 which was the tenth consecutive trading day where the closing price of the Company stock was at least $1.75.